Detalhe da pesquisa
1.
Estimating scenarios for survival time in patients with advanced melanoma receiving immunotherapy and targeted therapy.
Oncologist
; 2024 May 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38768122
2.
Measuring serum oestrogen levels in breast cancer survivors using vaginal oestrogens: a systematic review.
Breast Cancer Res Treat
; 2024 May 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38780887
3.
Timing of prognostic discussions in people with advanced cancer: a systematic review.
Support Care Cancer
; 32(2): 127, 2024 Jan 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38261070
4.
Telehealth cognitive behaviour therapy for the management of sleep disturbance in women with early breast cancer receiving chemotherapy: a feasibility study.
Support Care Cancer
; 32(6): 375, 2024 May 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38780707
5.
Pertuzumab study in the neoadjuvant setting for HER2-positive nonmetastatic breast cancer in Australia (PeRSIA).
Int J Cancer
; 152(2): 267-275, 2023 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36005450
6.
Long term risk of distant metastasis in women with non-metastatic breast cancer and survival after metastasis detection: a population-based linked health records study.
Med J Aust
; 217(8): 402-409, 2022 10 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-35987521
7.
Prevalence and severity of scanxiety in people with advanced cancers: a multicentre survey.
Support Care Cancer
; 30(1): 511-519, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34333717
8.
Using three scenarios to explain life expectancy in advanced cancer: attitudes of patients, family members, and other healthcare professionals.
Support Care Cancer
; 30(9): 7763-7772, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35701634
9.
Cardiac assessment in Australian patients receiving (neo)adjuvant trastuzumab for HER2-positive early breast cancer: a population-based study.
Breast Cancer Res Treat
; 187(3): 893-902, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33616773
10.
Experiences with scans and scanxiety in people with advanced cancer: a qualitative study.
Support Care Cancer
; 29(12): 7441-7449, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34076779
11.
Relationship between sleep disturbance, symptoms, and alcohol use in breast cancer survivors attending Sydney Cancer Survivorship Clinic.
Support Care Cancer
; 29(11): 6233-6242, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-33844082
12.
Correction: Treatment patterns and survival in HER2-positive early breast cancer: a whole-of-population Australian cohort study (2007-2016).
Br J Cancer
; 123(5): 868, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32472094
13.
Communicating prognostic information: what do oncologists think patients with incurable cancer should be told?
Intern Med J
; 50(12): 1492-1499, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31904887
14.
Treatment patterns and survival in HER2-positive early breast cancer: a whole-of-population Australian cohort study (2007-2016).
Br J Cancer
; 121(11): 904-911, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31673103
15.
Trastuzumab use in older patients with HER2-positive metastatic breast cancer: outcomes and treatment patterns in a whole-of-population Australian cohort (2003-2015).
BMC Cancer
; 19(1): 909, 2019 Sep 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31510955
16.
Correction to: Using three scenarios to explain life expectancy in advanced cancer: attitudes of patients, family members, and other healthcare professionals.
Support Care Cancer
; 32(6): 386, 2024 May 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38801545
17.
Association between ribociclib and changes in creatinine in patients with hormone receptor positive metastatic breast cancer.
Intern Med J
; 49(11): 1438-1442, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31713335
18.
Survival outcomes for Australian women receiving trastuzumab for HER2-positive metastatic breast cancer following (neo)adjuvant trastuzumab: a national population-based observational study (2006-2014).
Br J Cancer
; 118(3): 441-447, 2018 02 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29136405
19.
A randomised controlled trial of an advance care planning intervention for patients with incurable cancer.
Br J Cancer
; 119(10): 1182-1190, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30369600
20.
Long-term survival in trastuzumab-treated patients with HER2-positive metastatic breast cancer: real-world outcomes and treatment patterns in a whole-of-population Australian cohort (2001-2016).
Breast Cancer Res Treat
; 171(1): 151-159, 2018 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-29736743